Medtronic Study Detects Gene Associated with Sudden Cardiac Death

Medtronic plc (NYSE: MDT) today announced first-of-its-kind findings from two independent studies that have identified a gene associated with life-threatening abnormal heart rhythms. The study results were presented in a hotline session at the 2015 European Society of Cardiology (ESC) Congress in London. The studies evaluated genetic "markers" to determine which gene abnormalities may be associated with dangerous heart rhythms that can lead to sudden cardiac death (SCD).
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news